RAPP MICHAEL 4
4 · Zynerba Pharmaceuticals, Inc. · Filed May 2, 2018
Insider Transaction Report
Form 4
RAPP MICHAEL
10% Owner
Transactions
- Purchase
Common Stock
2018-05-02$10.46/sh+15,000$156,945→ 1,494,115 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.39 to $10.50, inclusive. The reporting person undertakes to provide to Zynerba, any security holder of Zynerba, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]Includes 80,467 shares transferred by Broadband Capital Management LLC ("BCM") to Reporting Person for no consideration. The Reporting Person was the Chairman and member of BCM.